BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 21367900)

  • 1. Regulation of antinucleoprotein IgG by systemic vaccination and its effect on influenza virus clearance.
    Lamere MW; Moquin A; Lee FE; Misra RS; Blair PJ; Haynes L; Randall TD; Lund FE; Kaminski DA
    J Virol; 2011 May; 85(10):5027-35. PubMed ID: 21367900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus.
    LaMere MW; Lam HT; Moquin A; Haynes L; Lund FE; Randall TD; Kaminski DA
    J Immunol; 2011 Apr; 186(7):4331-9. PubMed ID: 21357542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus.
    Carragher DM; Kaminski DA; Moquin A; Hartson L; Randall TD
    J Immunol; 2008 Sep; 181(6):4168-76. PubMed ID: 18768874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-protection against influenza virus infection by intranasal administration of nucleoprotein-based vaccine with compound 48/80 adjuvant.
    Zheng M; Liu F; Shen Y; Wang S; Xu W; Fang F; Sun B; Xie Z; Chen Z
    Hum Vaccin Immunother; 2015; 11(2):397-406. PubMed ID: 25607884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single dose of DNA vaccine based on conserved H5N1 subtype proteins provides protection against lethal H5N1 challenge in mice pre-exposed to H1N1 influenza virus.
    Chang H; Huang C; Wu J; Fang F; Zhang W; Wang F; Chen Z
    Virol J; 2010 Aug; 7():197. PubMed ID: 20727202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-dose vaccination of a recombinant parainfluenza virus 5 expressing NP from H5N1 virus provides broad immunity against influenza A viruses.
    Li Z; Gabbard JD; Mooney A; Gao X; Chen Z; Place RJ; Tompkins SM; He B
    J Virol; 2013 May; 87(10):5985-93. PubMed ID: 23514880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broadly protective immunity against divergent influenza viruses by oral co-administration of Lactococcus lactis expressing nucleoprotein adjuvanted with cholera toxin B subunit in mice.
    Lei H; Peng X; Jiao H; Zhao D; Ouyang J
    Microb Cell Fact; 2015 Aug; 14():111. PubMed ID: 26242406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A DNA vaccine-encoded nucleoprotein of influenza virus fails to induce cellular immune responses in a diabetic mouse model.
    Jamali A; Sabahi F; Bamdad T; Hashemi H; Mahboudi F; Kheiri MT
    Clin Vaccine Immunol; 2010 Apr; 17(4):683-7. PubMed ID: 20164252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of cross-protection against influenza A virus by DNA prime-intranasal protein boost strategy based on nucleoprotein.
    Luo J; Zheng D; Zhang W; Fang F; Wang H; Sun Y; Ding Y; Xu C; Chen Q; Zhang H; Huang D; Sun B; Chen Z
    Virol J; 2012 Nov; 9():286. PubMed ID: 23173785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broadly Protective CD8
    Zhang H; Zheng H; Guo P; Hu L; Wang Z; Wang J; Ju Y; Meng S
    J Virol; 2021 May; 95(12):. PubMed ID: 33827939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice.
    Altenburg AF; van de Sandt CE; van Trierum SE; De Gruyter HLM; van Run PRWA; Fouchier RAM; Roose K; Saelens X; Volz A; Sutter G; de Vries RD; Rimmelzwaan GF
    J Virol; 2016 Nov; 90(22):10209-10219. PubMed ID: 27581985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza A virus nucleoprotein derived from Escherichia coli or recombinant vaccinia (Tiantan) virus elicits robust cross-protection in mice.
    Huang B; Wang W; Li R; Wang X; Jiang T; Qi X; Gao Y; Tan W; Ruan L
    Virol J; 2012 Dec; 9():322. PubMed ID: 23272943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice.
    Asthagiri Arunkumar G; McMahon M; Pavot V; Aramouni M; Ioannou A; Lambe T; Gilbert S; Krammer F
    Vaccine; 2019 Sep; 37(37):5567-5577. PubMed ID: 31399277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intramuscular immunization of mice with live influenza virus is more immunogenic and offers greater protection than immunization with inactivated virus.
    Harris K; Ream R; Gao J; Eichelberger MC
    Virol J; 2011 May; 8():251. PubMed ID: 21600020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterosubtypic immunity to influenza mediated by liposome adjuvanted H5N1 recombinant protein vaccines.
    Thueng-in K; Maneewatch S; Srimanote P; Songserm T; Tapchaisri P; Sookrung N; Tongtawe P; Channarong S; Chaicumpa W
    Vaccine; 2010 Sep; 28(41):6765-77. PubMed ID: 20688037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza Antigens NP and M2 Confer Cross Protection to BALB/c Mice against Lethal Challenge with H1N1, Pandemic H1N1 or H5N1 Influenza A Viruses.
    Mytle N; Leyrer S; Inglefield JR; Harris AM; Hickey TE; Minang J; Lu H; Ma Z; Andersen H; Grubaugh ND; Guina T; Skiadopoulos MH; Lacy MJ
    Viruses; 2021 Aug; 13(9):. PubMed ID: 34578289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified vaccinia virus Ankara encoding influenza virus hemagglutinin induces heterosubtypic immunity in macaques.
    Florek KR; Weinfurter JT; Jegaskanda S; Brewoo JN; Powell TD; Young GR; Das SC; Hatta M; Broman KW; Hungnes O; Dudman SG; Kawaoka Y; Kent SJ; Stinchcomb DT; Osorio JE; Friedrich TC
    J Virol; 2014 Nov; 88(22):13418-28. PubMed ID: 25210172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses.
    Altstein AD; Gitelman AK; Smirnov YA; Piskareva LM; Zakharova LG; Pashvykina GV; Shmarov MM; Zhirnov OP; Varich NP; Ilyinskii PO; Shneider AM
    Arch Virol; 2006 May; 151(5):921-31. PubMed ID: 16292596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses.
    Price GE; Soboleski MR; Lo CY; Misplon JA; Pappas C; Houser KV; Tumpey TM; Epstein SL
    Vaccine; 2009 Nov; 27(47):6512-21. PubMed ID: 19729082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge.
    McMahon M; Asthagiri Arunkumar G; Liu WC; Stadlbauer D; Albrecht RA; Pavot V; Aramouni M; Lambe T; Gilbert SC; Krammer F
    Front Immunol; 2019; 10():2005. PubMed ID: 31497029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.